JPS5265295A - Production of antibiotic - Google Patents

Production of antibiotic

Info

Publication number
JPS5265295A
JPS5265295A JP51139656A JP13965676A JPS5265295A JP S5265295 A JPS5265295 A JP S5265295A JP 51139656 A JP51139656 A JP 51139656A JP 13965676 A JP13965676 A JP 13965676A JP S5265295 A JPS5265295 A JP S5265295A
Authority
JP
Japan
Prior art keywords
antibiotic
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51139656A
Other languages
English (en)
Inventor
Esu Keehan Jiin
Emu Keehan Furederitsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5265295A publication Critical patent/JPS5265295A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP51139656A 1975-11-24 1976-11-22 Production of antibiotic Pending JPS5265295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63456075A 1975-11-24 1975-11-24

Publications (1)

Publication Number Publication Date
JPS5265295A true JPS5265295A (en) 1977-05-30

Family

ID=24544292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51139656A Pending JPS5265295A (en) 1975-11-24 1976-11-22 Production of antibiotic

Country Status (16)

Country Link
JP (1) JPS5265295A (ja)
AR (1) AR224224A1 (ja)
AU (1) AU510252B2 (ja)
BE (1) BE848349A (ja)
CH (1) CH625803A5 (ja)
DE (1) DE2652678A1 (ja)
DK (1) DK497476A (ja)
ES (1) ES453508A1 (ja)
FR (1) FR2351979A1 (ja)
GB (1) GB1561108A (ja)
GR (1) GR61407B (ja)
HU (1) HU175266B (ja)
NL (1) NL7612932A (ja)
PT (1) PT65845B (ja)
SE (1) SE7612295L (ja)
ZA (1) ZA766986B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7800979L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
SE7800978L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
US4162193A (en) * 1977-08-19 1979-07-24 Merck & Co., Inc. Enzymatic cleavage of N-acyl-thienamycins
PH16708A (en) 1978-07-24 1984-01-20 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
DE2965923D1 (en) * 1979-08-28 1983-08-25 Merck & Co Inc Process for purifying thienamycin
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
WO2017132321A1 (en) * 2016-01-29 2017-08-03 The Johns Hopkins University Novel inhibitors of bacterial growth

Also Published As

Publication number Publication date
NL7612932A (nl) 1977-05-26
FR2351979B1 (ja) 1982-08-13
AU510252B2 (en) 1980-06-19
DE2652678A1 (de) 1977-06-02
HU175266B (hu) 1980-06-28
GR61407B (en) 1978-11-11
ES453508A1 (es) 1978-03-01
PT65845A (en) 1976-12-01
PT65845B (en) 1978-10-10
GB1561108A (en) 1980-02-13
AU1964576A (en) 1978-05-25
CH625803A5 (en) 1981-10-15
DK497476A (da) 1977-05-25
BE848349A (fr) 1977-05-16
FR2351979A1 (fr) 1977-12-16
ZA766986B (en) 1978-06-28
AR224224A1 (es) 1981-11-13
SE7612295L (sv) 1977-05-25

Similar Documents

Publication Publication Date Title
JPS51118763A (en) Production of alkylenecarbonate
JPS5236683A (en) Production of riphamycin
JPS5212162A (en) Production of phenylindoline
JPS51141897A (en) Production of riphamycin
JPS5251392A (en) Production of triazolopyridazinones
JPS51131873A (en) Production of 44loneralkyll 55cyanoooxazole
JPS51128494A (en) Production of novel antibiotic substance
JPS5265295A (en) Production of antibiotic
JPS525762A (en) Production of betaa acylpyrol
JPS5248698A (en) Production of riphamycin
JPS5321193A (en) Production of novel antibiotic
JPS51142597A (en) Production of novel antibiotic
JPS5289667A (en) Production of nnsubstituted spirolaltam
JPS5248689A (en) Production of pyrazolopyridineketones
JPS51115465A (en) Production of 55phenyll 22framidoxime
JPS5219695A (en) Production of tetrahydrothiopyranopyrazols
JPS5227758A (en) Production of 22methyll 11naphthol
JPS5248662A (en) Production of 44hydroxymethyll 22pyrorysines
JPS5273858A (en) Production of phospholenee 11calcogenite
JPS5236690A (en) Production of 33methoxymethlcephalosporin
JPS5246100A (en) Production of pyrazolopyridopirimidine
JPS5212991A (en) Production of bioprotein
JPS5273859A (en) Production of 77hydroxyy 22nitrobenzofuran
JPS51128997A (en) Production of pyrazolopyridineketones
JPS525760A (en) Production of 22pyrrolidone